QUESTIONNAIRE BASED STUDY ON THE ASSESSMENT OF PHARM.D INTERNS’ KNOWLEDGE, ATTITUDE, AND PRACTICES (KAP) REGARDING THE PHARMACOVIGILANCE
Background: Lack of awareness about Pharmacovigilance (PV) is one of the most important causes of under-reporting, which is widespread and poses a daunting challenge in India.
Objectives: The present study was contemplated and done to assess the knowledge, attitude, and practices (KAP) towards ADR reporting and PV of the Pharm.D interns for the first time in south India, to get an insight into their awareness and reporting culture.
Methods: A cross-sectional descriptive KAP questionnaire-based study was conducted for 6 months on Pharm.D interns.
Results: A total of 603 Pharm.D interns were participated, among them 578 (95.85%) were considered for the analysis. On an average of 78.25 % of the participants had a good knowledge, around 82% were aware that patients’ will be benefited from the ADR reporting. The majority of the participants had a positive attitude. And 59 % had reported the ADRs through different ADR reporting procedures 52 % were advised the awareness programs for improving the reporting culture, and 34 % had the difficulty in deciding or diagnosing the ADR.
Conclusion: The knowledge, Attitude, and Practice of the Pharm.D interns towards the ADR reporting and PV is appreciable and may reduce the burden on the other HCPs and improve patient care.
2. WHO: Essential medicines and health products. https://www.who.int/medicines/news/glob_pharmvig_database_qa/en/; Accessed 24.04.2020
3. Adverse Drug Reactions. https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=4&cad=rja&uact=8&ved=2ahUKEwiqnarwhYvpAhXW7XMBHf2HD8AQFjADegQIAxAB&url=https%3A%2F%2Fwww.accp.com%2Fdocs%2Fbookstore%2Fpsap%2F2015B2.SampleChapter.pdf&usg=AOvVaw0StpCVJE9qyEdheOdDmqWo; Accessed 21.04.2020
4. WHO: Policy Implementation Package for New TB Drug Introduction. https://www.who.int/tb/PIPnewTBdrugs.pdf; Accessed 27.04.2020.
5. Saleh HA, knowledge, attitude and practice of health professionals towards adverse drug reactions reporting; EJPMR. 2016;3:12-21.
6. Gosh AK, De A, Bala NN. Current problems and future aspects of pharmacovigilance. Int J Pharm Bio Sci. 2011;2:15?28.
7. Alsaleh FM, Lemay J, Al Dhafeeri RR, AlAjmi S, Abahussain, Bayoudl T. Adverse drug reaction reporting among physicians working in private and government hospitals in Kuwait. Saudi Pharma J. 2017;25:1184–93.
8. WHO’s Safety of Medicines: A Guide to Detecting and Reporting Adverse Drug Reactions. WHO/EDM/QSM/2002. Geneva, Switzerland: World Health Organization; 2002
9. Kalaiselvan V, Sushma S, Abhishank S, Suresh KG. Pharmacovigilance in India: Present scenario and future challenges. Drug Saf. 2019;42:339-46. (Abstract only) doi: 10.1007/s40264-018-0730-7.
10. PVPI: Introduction & Function. http://www.ipc.gov.in/PvPI/about.html; Accessed 28.04.2020
11. Komaram RB and Dhar M: A study on assessment of knowledge, attitude and practice regarding pharmacovigilance among healthcare professionals in a tertiary care hospital, Andhra Pradesh. Int J Pharm Sci Res. 2016;7:5082-87. doi:10.13040/IJPSR.0975-8232.
12. Manjhi PK, Kumar M, Dikshit H, Mohan L, Mishra H. A survey on knowledge, attitude and practice of pharmacovigilance and adverse drug reaction reporting among healthcare professionals in a tertiary care hospital of Bihar, India. Int J Basic Clin Pharmacol 2016;5:2566-71.
13. Farha RA, Hammour KA, Rizik M, Aljanabi R, Alsakran L. Effect of educational intervention on healthcare providers’ knowledge and perception towards pharmacovigilance: A tertiary teaching hospital experience. Saudi Pharm J. 2018;26:611–16. https://doi.org/10.1016/j.jsps.2018.03.002.
14. Goel D, Farooq M. Impact of educational intervention on knowledge, attitude and practice of Pharmacovigilance among interns. Adv Hum Biol. 2017;7:75-79. doi: 10.4103/AIHB.AIHB_7_17.
15. Singh J, Singh H, Rohilla R, Kumar R, Gautam CS. Lack of awareness of pharmacovigilance among young health-care professionals in India: An issue requiring urgent intervention. Int J App Basic Med Res. 2018;8:158-63.
16. Alsaleh FM, Alzaid SW, Abahussain EA, Bayoud T, Lemay J. Knowledge, attitude and practices of pharmacovigilance and adverse drug reaction reporting among pharmacists working in secondary and tertiary governmental hospitals in Kuwait. Saudi Pharm J. 2017;25:830–37.
17. Joubert MC, Naidoo P. Knowledge, perceptions and practices of pharmacovigilance amongst community and hospital pharmacists in a selected district of North West Province, South Africa. Health sa gesondheid. 2016;21:238-44.
18. Saleh HA. Knowledge, attitude and practice of health professionals towards adverse drug reactions reporting; EJPMR, 2016;3:12-21.
19. Kalaiselvan V., Prasad, T, Bisht A., Singh S., Singh GN. Adverse drug reactions reporting culture in Pharmacovigilance Programme of India. The Ind J of med res. 2014; 140, 563–64.
20. The Pharmacy Council of India. http://www.pci.nic.in/. Accessed 12.03.2020.
21. Tew MM, Teoh BC, Mohd Baidi AS, Saw HL Assessment of Knowledge, Attitude and Practices of Adverse Drug Reaction Reporting among Doctors and Pharmacists in Primary Healthcare. Adv Pharmacoepidemiol Drug Saf. 2016;5:206. doi:10.4172/2167-1052.1000206
22. Sushma M, Kavitha R, Divyasree S, Deepashri B, Jayanthi C R. A questionnaire study to assess the knowledge, attitude and practice of Pharmacovigilance in a paediatric tertiary care centre J. Chem. Pharm. Res. 2011;3:416-22.
23. Garg P, Sharma V, Bajaj JK. Assessment of knowledge, attitude and practice of Pharmacovigilance among the interns in a tertiary care hospital in northern India- A questionnaire based study. Int J Med and Dent Sci. 2017;6:1498-1503.
24. Shakya GR, Shrestha D, Thapa R. Assessment on knowledge, attitude and practice of pharmacovigilance among the healthcare professionals in a tertiary hospital of Kathmandu. Nepal Med Coll J. 2019;21:53-9.
25. PVPI: ADR Reporting Form. http://www.ipc.gov.in/PvPI/adr.html. Accessed 01.03.2020.
26. IPC-PvPI guidance document for spontaneous Adverse Drug Reaction Reporting Version: 1.0. http://www.ipc.gov.in/PvPI/pub/Guidance%20Document%20for%20spontaneous%20Adverse%20Drug%20Reaction%20Reporting.pdf. Accessed 01.03.2020.
27. Belete KA, Tessema TB. Health Care Professionals’ Knowledge, Attitude, and Practice towards Adverse Drug Reaction Reporting and Associated Factors at Selected Public Hospitals in Northeast Ethiopia: A Cross-Sectional Study. Hindawi BioMed Res Int. Volume 2019 doi: https://doi.org/10.1155/2019/8690546
28. Subish P, Mohamed I I, Pranaya M. Health professionals' knowledge, attitude and practices towards pharmacovigilance in Nepal. Pharm Pract (Granada). 2011;9:228–35. doi: 10.4321/s1886-36552011000400008
29. Opadeyi AO, Réglat AF, Ambrose O. Isah. Educational intervention to improve the knowledge, attitude and practice of healthcare professionals regarding pharmacovigilance in South-South Nigeria. Ther Adv Drug Saf. 2019;10:1–12. doi: 10.1177/2042098618816279.
30. AlShammari TM, Almoslem MJ. Knowledge, attitudes & practices of healthcare professionals in hospitals towards the reporting of adverse drug reactions in Saudi Arabia: A multi-centre cross sectional study. Saudi Pharm J. 2018;26:925–31. doi: https://doi.org/10.1016/j.jsps.2018.04.012
31. Joubert MC, Naidoo P. Knowledge, perceptions and practices of pharmacovigilance amongst community and hospital pharmacists in a selected district of North West Province, South Africa. Health sa gesondheid. 2016;2:238-44. doi: http://dx.doi.org/10.1016/j.hsag.2016.04.005.
32. Katekhaye VM, Kadhe NG, John J, Pawar SR. Knowledge, attitude and practice of pharmacovigilance among medical professionals at a tertiary care hospital in Mumbai, Maharashtra, India. Int J Res Med Sci. 2017;5:156-161.
33. Rajalakshmi R, Vasundara Devi B, Durga Prasad TS, Swetha S, Dharini B. Knowledge, Attitude and Practice towards Pharmacovigilance and Adverse Drug Reaction Reporting Among Nurses in A Tertiary Care Hospital, Tirupati. IJPCR, 2017;9:683-89.
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.